These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 37845582)

  • 1. Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery.
    Coll RP; Bright SJ; Martinus DKJ; Georgiou DK; Sawakuchi GO; Manning HC
    Mol Imaging Biol; 2023 Dec; 25(6):991-1019. PubMed ID: 37845582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Lee D; Li M; Bednarz B; Schultz MK
    Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
    Sgouros G; Hobbs R; Josefsson A
    Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
    Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box.
    Sgouros G; Frey E; Du Y; Hobbs R; Bolch W
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):18-29. PubMed ID: 34782911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Radiotherapy with Alpha-Particle Emitting Radionuclides Seminar, November 18, 2004, Cracow, Poland.
    Zalutsky MR; Petelenz B
    Nucl Med Rev Cent East Eur; 2004; 7(2):195. PubMed ID: 15968616
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of Targeted Alpha Particle Therapy for Solid Tumors.
    Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
    Kozempel J; Mokhodoeva O; Vlk M
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing
    Yang H; Wilson JJ; Orvig C; Li Y; Wilbur DS; Ramogida CF; Radchenko V; Schaffer P
    J Nucl Med; 2022 Jan; 63(1):5-13. PubMed ID: 34503958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.
    Radchenko V; Morgenstern A; Jalilian AR; Ramogida CF; Cutler C; Duchemin C; Hoehr C; Haddad F; Bruchertseifer F; Gausemel H; Yang H; Osso JA; Washiyama K; Czerwinski K; Leufgen K; Pruszyński M; Valzdorf O; Causey P; Schaffer P; Perron R; Maxim S; Wilbur DS; Stora T; Li Y
    J Nucl Med; 2021 Nov; 62(11):1495-1503. PubMed ID: 34301779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides.
    Li WB; Bouvier-Capely C; Saldarriaga Vargas C; Andersson M; Madas B
    Radiat Environ Biophys; 2022 Nov; 61(4):579-596. PubMed ID: 36239799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why bother with alpha particles?
    King AP; Lin FI; Escorcia FE
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):7-17. PubMed ID: 34175980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.
    Sgouros G; Roeske JC; McDevitt MR; Palm S; Allen BJ; Fisher DR; Brill AB; Song H; Howell RW; Akabani G; ; Bolch WE; Brill AB; Fisher DR; Howell RW; Meredith RF; Sgouros G; Wessels BW; Zanzonico PB
    J Nucl Med; 2010 Feb; 51(2):311-28. PubMed ID: 20080889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides.
    Morgan KA; Rudd SE; Noor A; Donnelly PS
    Chem Rev; 2023 Oct; 123(20):12004-12035. PubMed ID: 37796539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Case for Dosimetry in Alpha-Emitter Therapy.
    Sgouros G
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S45-S46. PubMed ID: 31537496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
    Lindegren S; Frost SH
    Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?
    Guerard F; Barbet J; Chatal JF; Kraeber-Bodere F; Cherel M; Haddad F
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):161-7. PubMed ID: 25752501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.
    Vaidyanathan G; Zalutsky MR
    Curr Radiopharm; 2011 Oct; 4(4):283-94. PubMed ID: 22202151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.